SEC Form 4 · accession 0001209191-18-040121
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Charles Gorman
Officer — Chief Executive Officer · Director
Period of report
Jun 28, 2018
Accepted (ET)
Jun 29, 2018 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 28, 2018 | M | 23,168 | $5.76 | A | 370,201 | D | |
| Common Stock | Jun 28, 2018 | M | 16,551 | $8.66 | A | 386,752 | D | |
| Common Stock | Jun 28, 2018 | M | 10,199 | $8.65 | A | 396,951 | D | |
| Common Stock | Jun 28, 2018 | M | 7,142 | $19.59 | A | 404,093 | D | |
| Common Stock | Jun 28, 2018 | M | 864 | $32.99 | A | 404,957 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionF1 | $5.76 | Jun 28, 2018 | M | 23,168 | D | Sep 25, 2011 | Aug 25, 2021 | Common Stock | 23,168 | 0 | D |
| Incentive Stock OptionF2 | $8.66 | Jun 28, 2018 | M | 16,551 | D | Feb 12, 2012 | Jan 12, 2022 | Common Stock | 16,551 | 0 | D |
| Incentive Stock OptionF3 | $8.65 | Jun 28, 2018 | M | 10,199 | D | Feb 10, 2013 | Jan 10, 2023 | Common Stock | 10,199 | 0 | D |
| Incentive Stock OptionF4 | $19.59 | Jun 28, 2018 | M | 7,142 | D | Feb 16, 2014 | Jan 16, 2024 | Common Stock | 7,142 | 0 | D |
| Incentive Stock OptionF5 | $32.99 | Jun 28, 2018 | M | 864 | D | Mar 3, 2015 | Feb 3, 2025 | Common Stock | 864 | 3,031 | D |
Explanation of responses
- F1Represents option of which 1/36th of the shares underlying the option vested on September 25, 2011 and an additional 1/36th of the shares underlying the option vested each month thereafter.
- F2Represents option of which 1/48th of the shares underlying the option vested on February 12, 2012 and an additional 1/48th of the shares underlying the option vested each month thereafter.
- F3Represents option of which 1/48th of the shares underlying the option vested on February 10, 2013 and an additional 1/48th of the shares underlying the option vested each month thereafter.
- F4Represents option of which 1/48th of the shares underlying the option vested on February 16, 2014 and an additional 1/48th of the shares underlying the option vested each month thereafter.
- F5Represents option of which 1/48th of the shares underlying the option vested on March 3, 2015 and an additional 1/48th of the shares underlying the option vested each month thereafter.